{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:43:37Z","timestamp":1792637017096,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jconrel.2023.07.021","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T19:41:30Z","timestamp":1689795690000},"page":"718-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"special_numbering":"C","title":["Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy"],"prefix":"10.1016","volume":"360","author":[{"given":"Zhenmei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongdeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2021","key":"10.1016\/j.jconrel.2023.07.021_bb0005","first-page":"209","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0015","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2008.02.090","article-title":"Diagnosis and treatment of hepatocellular carcinoma","volume":"134","author":"El-Serag","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0020","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11427-016-5027-4","article-title":"Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors","volume":"59","author":"Zhang","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0030","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.29904","article-title":"Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification","volume":"68","author":"Kurebayashi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0035","doi-asserted-by":"crossref","first-page":"35056","DOI":"10.1038\/srep35056","article-title":"Regulatory T cells, especially ICOS(+) FOXP3(+) regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival","volume":"6","author":"Tu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0045","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2014.10.029","article-title":"Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma","volume":"62","author":"Yeung","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cmi.12580","article-title":"Macrophages: sentinels and regulators of the immune system","volume":"18","author":"Franken","year":"2016","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0060","doi-asserted-by":"crossref","first-page":"eabn1128","DOI":"10.1126\/scitranslmed.abn1128","article-title":"Intracavity generation of glioma stem cell\u2013specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy","volume":"14","author":"Chen","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091339","article-title":"Glypican 3-targeted therapy in hepatocellular carcinoma","volume":"11","author":"Nishida","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0070","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.ymthe.2021.01.006","article-title":"A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC","volume":"29","author":"Du","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0075","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ymthe.2017.08.005","article-title":"A novel vaccine targeting glypican-3 as a treatment for hepatocellular carcinoma","volume":"25","author":"Wu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0080","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1158\/1078-0432.CCR-19-3259","article-title":"Chimeric antigen receptor-glypican-3 T-cell therapy for advanced hepatocellular carcinoma: results of phase I trials","volume":"26","author":"Shi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0085","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-11-3044","article-title":"Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival","volume":"18","author":"Sawada","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0090","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0100","doi-asserted-by":"crossref","first-page":"11103","DOI":"10.1073\/pnas.1305569110","article-title":"Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response","volume":"110","author":"Tseng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0105","article-title":"Secreted expression of mRNA-encoded truncated ACE2 variants for SARS-CoV-2 via lipid-like nanoassemblies","volume":"33","author":"Li","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0110","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"vol. 383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12018","article-title":"Current advances in non-viral gene delivery systems: liposomes versus extracellular vesicles","volume":"1","author":"Belhadj","year":"2023","journal-title":"BMEMat"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0125","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0130","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1038\/s41467-022-32281-5","article-title":"Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo","volume":"13","author":"Ni","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0135","doi-asserted-by":"crossref","first-page":"19244","DOI":"10.1021\/acsnano.1c04862","article-title":"Simultaneous, single-particle measurements of size and loading give insights into the structure of drug-delivery nanoparticles","volume":"15","author":"Kamanzi","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0140","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1021\/acs.nanolett.5b03528","article-title":"An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo","volume":"15","author":"Li","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0145","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/ja107583h","article-title":"Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles","volume":"133","author":"Monopoli","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0150","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0160","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1021\/acsnano.0c00269","article-title":"Size and charge adaptive clustered nanoparticles targeting the biofilm microenvironment for chronic lung infection management","volume":"14","author":"Gao","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0165","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers","volume":"11","author":"Schottler","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.addr.2016.04.030","article-title":"A high-density lipoprotein-mediated drug delivery system","volume":"106","author":"Mo","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ncb3090","article-title":"Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth","volume":"17","author":"Zhou","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/343170a0","article-title":"Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis","volume":"343","author":"Savill","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0195","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0200","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0205","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/acsnano.6b00053","article-title":"Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona","volume":"10","author":"Saha","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41565-018-0344-3","article-title":"Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles","volume":"14","author":"Vu","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0215","doi-asserted-by":"crossref","first-page":"52866","DOI":"10.18632\/oncotarget.17905","article-title":"Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager","volume":"8","author":"Bi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202103258","article-title":"Nanocomplex-mediated in vivo programming to chimeric antigen receptor-M1 macrophages for cancer therapy","volume":"33","author":"Kang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0225","article-title":"mRNA delivery of a bispecific single-domain antibody to polarize tumor-associated macrophages and synergize immunotherapy against liver malignancies","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0230","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0240","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1021\/acsnano.9b07896","article-title":"In situ mannosylated nanotrinity-mediated macrophage remodeling combats Candida albicans infection","volume":"14","author":"Gao","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2019.03.009","article-title":"Tumor-specific macrophage targeting through recognition of retinoid X receptor beta","volume":"301","author":"Tang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.021_bb0255","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41578-023-00552-2","article-title":"The protein corona from nanomedicine to environmental science","volume":"8","author":"Mahmoudi","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0260","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1309\/HCQWPWD50XHD2DW6","article-title":"Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples","volume":"129","author":"Baumhoer","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jconrel.2023.07.021_bb0265","first-page":"A503","article-title":"482\u00a0ATG-031, a first-in-class anti-CD24 antibody, showed potent preclinical anti-tumor efficacy by blocking \u201cdon\u2019t-eat-me\u201d signal","volume":"10","author":"Chen","year":"2022","journal-title":"J. Immunother. Cancer"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:53:05Z","timestamp":1759164785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923004455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":53,"alternative-id":["S0168365923004455"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}